Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of D...( NAPA Calif. Feb. 5 /- Senetek PLC...),Health
Navigation Links
Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
Date:2/5/2008
NAPA, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today announced the debut of Pyratine-6(TM) at the 66th Annual Meeting of the American Academy of Dermatology in San Antonio, Texas.
Pyratine-6(TM), Senetek's exclusive second generation cytokinin, has been clinically proven to be effective in correcting visible signs of skin aging and significantly reducing erythema as early as two weeks from onset of use.
The Annual Meeting of the American Academy of Dermatology runs from February 1 - 5, 2008. Approximately 7,000 medical personnel are registered to attend.
Commenting on the debut, Mr. Frank Massino, Senetek's Chairman and Chief Executive Officer stated, "We are delighted to see this compelling therapeutic come to the market and are very pleased by the reception Pyratine-6(TM) has received from dermatologists at this important conference. Pyratine-6(TM) has been successfully clinically tested and has shown attributes more beneficial to treatment than any predecessor compound."
About Senetek PLC
Senetek PLC (OTC Bulletin Board: SNKTY) is a Life Sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The Company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of the best-selling anti-aging product sold in the North American physician market.
For more information, visit the company's website at http://www.senetekplc.com.
This news release contains
'/>"/>
| SOURCE Senetek PLC Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Senetek PLC Reports Third Quarter 2007 Financial Results
2. Coherent Announces Director Slate for Upcoming Annual Meeting
3. MAP Pharmaceuticals Announces Resignation of Chief Medical Officer
4. CorVel Announces Record Earnings Per Share
5. Better Nutrition Announces Best Of Beauty Awards Winners Showcasing the Best Natural Beauty Products of 2008
6. Naviscan Announces a New Chairman and Board Member
7. Globus Medical Announces Record Revenue for 2007
8. HealthFitness Announces Executive Changes: Chief Operations Officer And New Medical Officer Appointed; Vice Chairman Retires
9. Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008
10. Sergeants(R) Pet Care Products Announces Cause Marketing Partnership With the National Wildlife Federation
11. Poniard Pharmaceuticals Announces Upcoming Conference Participation
Post Your Comments:
(Date:12/4/2009)...c. 4 , ,What: Humana ( h..., health benefits provider, is intro...es.com ), a senior-friendly dance pad, ...Tues., Dec. 8 at 1 p.m. The festive...en to the public, will feature Dancetown, ...
(Date:12/4/2009)...RNewswire/ -- PLUS Diagnostics announced today t...gy services with the launch of a national hematolo...e company,s expansion from a regional laboratory t...fering diagnostic services across a full range of ...d now hematology/oncology. ,, PLUS Diagnostics...
(Date:12/4/2009)...wswire/ -- The National Cancer Institute has award... Hutchinson Cancer Research Center to become the n...rvice Contact Center. ,, The move will create 6...ing the size of its current CIS workforce - once t... is scheduled for March 15, 2010. The Seattle CIS ...
(Date:12/4/2009)...s multi-language patient education leaflets suppor...ds for language access in healthcare organizations...cember 5, 2009 -- Lexi-Comp, Inc., a provider of c...ent education materials for healthcare institution...cation between the health care professional and th...
(Date:12/4/2009)...et herpes zoster virus, study finds , , ...e vaccinated against chicken pox may also have inc...uggest. , U.S. researchers looked at the health...a who were vaccinated with the varicella (chicken ...verage of 2.5 years after receiving the chicken po...
Breaking Medicine News(10 mins):Health News:Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 3Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2Health News:Lexi-Comp Focused on Improving Patient Communication in Healthcare Institutions Treating Diverse Patient Populations 2Health News:Lexi-Comp Focused on Improving Patient Communication in Healthcare Institutions Treating Diverse Patient Populations 3[0] Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee[0] PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services[0] Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service[0] Lexi-Comp Focused on Improving Patient Communication in Healthcare Institutions Treating Diverse Patient Populations [0] Chicken Pox Shot Protects Against Shingles, Too
.... 7 Large employers say they,are not ready to bai...ealth,insurance coverage in the United States, acc...tisan Employee Benefit Research Institute (EBRI). ...picture could shift quickly if one large employer ...
... vehicles that run on both conventional gasoline a...ap until more sustainable technology is developed,...e Inderscience publication International Journal o...ric vehicles. , Jean-Jacques Chanaron Research Di...
... Establish Norman E. Borlaug Hall of Laureates, D... announced a $1 million contingent donation to fun...rld Food Prize in Des Moines. The donation,will su...business Pioneer Hi-Bred., "The World Food Prize ...
...soles will also be introduced, AMHERST, Mass., Fe...les, has partnered with Merrell to incorporate its...tyles. By early 2008,Merrell will expand the numbe...ll introduce a new line of aftermarket insoles,to ...
...vailable From Pantek Technologies Corp. With Mass ...8, HERZLIYA, Israel, February 7 Dblur, the devel...ced the availability of a,stand-alone chip that in... to 3.2Mp. Samples are currently available from Pa...
...eria found in healthy women help to reduce the amo...ke it more difficult for the virus to spread, boos...day be tapped in the fight against HIV. , The fin...fort to learn more about how HIV survives and spre...
Other Medicine News:Health News:EBRI Policy Forum: Large Employers Continue to Offer Health Benefits 2Health News:The trouble with hybrids 2Health News:DuPont Pledges $1 Million to World Food Prize 2Health News:DuPont Pledges $1 Million to World Food Prize 3Health News:Merrell Updates Performance Line with the Launch of OrthoLite Insoles 2Health News:Dblur Announces the Availability of a Software Lens(TM) Enabled Chip 2Health News:Dblur Announces the Availability of a Software Lens(TM) Enabled Chip 3Health News:'Good bacteria' in women give clues for slowing HIV transmission 2Health News:'Good bacteria' in women give clues for slowing HIV transmission 3EBRI Policy Forum: Large Employers Continue to Offer Health BenefitsThe trouble with hybridsDuPont Pledges $1 Million to World Food PrizeMerrell Updates Performance Line with the Launch of OrthoLite InsolesDblur Announces the Availability of a Software Lens(TM) Enabled Chip'Good bacteria' in women give clues for slowing HIV transmission
(Date:12/3/2009)...wire/ -- ParagonRx, a Delaware-based company speci...mal medication use, will host a free webinar on We...MS - Risk Evaluation Mitigation Strategy - program...nt. Dr. Gary Slatko, chief medical officer of Par...rograms, will lead the one-hour program beginning ...
(Date:12/3/2009)...stCall/ -- Cardium Therapeutics (NYSE Amex: CXM )... Tissue Repair Company, submitted a 510(k) premark... Administration (FDA) seeking marketing clearance ... positive data from the Company,s recently complet...sion with the FDA covers Excellagen XL(TM) and Ex...
(Date:12/3/2009)...RNewswire-FirstCall/ -- Each year, hundreds of und...(U.S.) and Europe participate in the Amgen Scholar...nder renowned faculty members at the world,s leadi...present and future - will have exclusive access to...scholars.com . ,, "The new Web site is designe...
Breaking Medicine Technology:Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 2New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 3Medco to Present at November 2009 Investor Conferences 5692 1Medco to Present at November 2009 Investor Conferences 5692 2LA BioMed researcher to be honored 60089 1LA BioMed researcher to be honored 60089 2Science at the petascale 3A Roadrunner results unveiled 60085 1Science at the petascale 3A Roadrunner results unveiled 60085 2Science at the petascale 3A Roadrunner results unveiled 60085 3[0] Webinar to Explore FDA Draft REMS Guidance and Its Implications for Lifecycle Management[0] Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds[0] New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
...Mar 22, 2007 - Aeolus,Pharmaceuticals, Inc. (OTCBB...f the analysis of results from the Company,s phase.... The clinical,direction for AEOL 10150 is current...ts for an efficacy study as a protector of healthy...head and neck,cancer and Amyotrophic Lateral Scler...
...--Mar 22, 2007 - FzioMed,Inc. announced today tha...thetic dermal fillers is being presented at the,An...arlo March,22-24, 2007., In 2006, FzioMed launched...n-permanent, synthetic filler created from the,com...s a completely,new class of filler for the correct...
Other Medicine Technology:Aeolus Pharmaceuticals Announces Successful Completion of Multiple,Dose Safety Study of AEOL 10150 2Aeolus Pharmaceuticals Announces Successful Completion of Multiple,Dose Safety Study of AEOL 10150 3Aeolus Pharmaceuticals Announces Successful Completion of Multiple,Dose Safety Study of AEOL 10150 4Laresse Dermal Filler Research Presented at Anti-Aging World,Congress 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |